Post Job

Explore Jobs

Find Specific Jobs

Explore Careers

Explore Professions

Best Companies

Explore Companies

C

CRISPR Therapeutics CEO and Leadership

Zippia Score 4.6
Job Openings (2)
OverviewJobsSalaryRevenue

Reviews

HistoryCompetitors

CEO & Executives

CRISPR Therapeutics CEO and Executives

Executive Summary. Based on our data team's research, Samarth Kulkarni is the CRISPR Therapeutics's CEO. CRISPR Therapeutics has 304 employees, of which 27 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The CRISPR Therapeutics executive team is 37% female and 63% male.
  • 58% of the management team is White.
  • 9% of CRISPR Therapeutics management is Hispanic or Latino.
  • 13% of the management team is Black or African American.
Work At CRISPR Therapeutics?
C
Share Your Experience

Rate CRISPR Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
S
Samarth Kulkarni

CEO

Samarth Kulkarni's LinkedIn

D
Dr. Rodger Novak

Co-Founder and President

Dr. Rodger Novak's LinkedIn

E
Emmanuelle Charpentier

Board Member

S
Shaun Foy

Co-Founder

Shaun Foy's LinkedIn

C
Chad Cowan

Scientific Founder

C
Craig Mello

Board Member

D
Daniel Anderson

Board Member

D
Dr. Matthew Porteus

Board Member

L
Lawrence Otto Klein

Chief Operating Officer

Lawrence Otto Klein's LinkedIn

As Chief Operating Officer, Dr. Lawrence Klein has responsibility for corporate strategy, business development, alliance management, and program management across the company’s research and development portfolio. Since joining CRISPR in 2016, Lawrence was a key contributor in developing the company’s initial corporate strategy, and led the formation of a number of the company’s strategic collaborations. Before joining our company, Lawrence was an Associate Partner at McKinsey & Company where he was a leader in the biotech practice and served a number of biotechnology companies on a wide range of topics from strategy to operations. Lawrence received a Ph.D. from Stanford University, where he conducted research in the field of T cell immunology and published in several leading scientific journals. He also holds a B.S. from the University of Wisconsin at Madison.

J
James R. Kasinger

General Counsel and Secretary

James R. Kasinger's LinkedIn

C

Do you work at CRISPR Therapeutics?

Does the leadership team provide a clear direction for CRISPR Therapeutics?

CRISPR Therapeutics Jobs

CRISPR Therapeutics Founders

Name & TitleBio
D
Dr. Rodger Novak

Co-Founder and President

Dr. Rodger Novak's LinkedIn

E
Emmanuelle Charpentier

Board Member

S
Shaun Foy

Co-Founder

Shaun Foy's LinkedIn

C
Chad Cowan

Scientific Founder

C
Craig Mello

Board Member

D
Daniel Anderson

Board Member

D
Dr. Matthew Porteus

Board Member

And if you're looking for a job, here are the top jobs CRISPR Therapeutics is hiring right now:

  1. Managers, All Other
  2. Helpers--Production Workers

CRISPR Therapeutics Board Members

Name & TitleBio
S
Samarth Kulkarni

CEO

Samarth Kulkarni's LinkedIn

D
Dr. Rodger Novak

Co-Founder and President

Dr. Rodger Novak's LinkedIn

E
Emmanuelle Charpentier

Board Member

S
Shaun Foy

Co-Founder

Shaun Foy's LinkedIn

C
Craig Mello

Board Member

D
Daniel Anderson

Board Member

D
Dr. Matthew Porteus

Board Member

J
James R. Kasinger

General Counsel and Secretary

James R. Kasinger's LinkedIn

B
Bradley J. Bolzon

Board Member

D
Douglas A. Treco

Board Member

CRISPR Therapeutics Executives FAQs

Related Company Executives

Working At Related Companies

Related Company Jobs

CRISPR Therapeutics Highest Paying Jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of CRISPR Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about CRISPR Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at CRISPR Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by CRISPR Therapeutics. The data presented on this page does not represent the view of CRISPR Therapeutics and its employees or that of Zippia.

CRISPR Therapeutics may also be known as or be related to CRISPR THERAPEUTICS AG, CRISPR Therapeutics, CRISPR Therapeutics AG, Crispr Therapeutics and Crispr Therapeutics, Inc.